TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 16 Sept 2022, 08:41 BST

Official UK procurement notice

Generic and Biosimilar Cancer Medicines

Official notice

Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") (NHS & healthcare)

Framework agreement41 lotsGoodsOpen procedureSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: Scotland (UKM)
Framework ceiling (notional)£59,145,973total for 41 lots · framework ceiling, not attributable revenue
Submissions closed 17 Oct 2022awarded 23 Dec 2022
Lots 41see the lot list below

What is being bought41 lots · detail below

Published requirement description

This Framework Agreement is for the supply of generic and biosimilar cancer medicines to NHS Scotland.

The Goods were separated into forty-one (41) categories, each of which is identified as a “Lot”.

Full details of each awarded Lot is contained in section II.2 of this Notice.

CPV: Pharmaceutical products

How this framework works

From the published notice
Bids received
5 bids on the busiest of 25 lots · 29 suppliers appointed

Lots and requirements (41)Procurement structure

25 of 41 loaded on this page

Showing the first 25 of 41 published lots; the full list is in the JSON and Markdown mirrors of this notice. 41 lots · all with a published value · same evaluation weights on every lot.

Lot #1Bendamustine Powder For Solution For InfusionAwardedRenewalPublished value£94,841

Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #2Capecitabine TabletsAwardedRenewalPublished value£910,974

Supply of Capecitabine Tablets to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #3Carboplatin InjectionAwardedRenewalPublished value£596,546

Supply of Carboplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #4Cisplatin InjectionAwardedRenewalPublished value£186,020

Supply of Cisplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #5Cyclophosphamide Injection, Powder For ReconstitutionAwardedRenewalPublished value£267,442

Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #6Cytarabine InjectionsAwardedRenewalPublished value£104,724

Supply of Cytarabine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #7Dacarbazine InjectionsAwardedRenewalPublished value£592,972

Supply of Dacarbazine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #8Disodium Folinate InjectionAwardedRenewalPublished value£442,064

Supply of Disodium Folinate Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #9Docetaxel Concentrate For Solution For InfusionAwardedRenewalPublished value£333,456

Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #10Doxorubicin Hydrochloride InjectionsAwardedRenewalPublished value£60,002

Supply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #11Fluorouracil 25MG/ML InjectionRenewalPublished value£44,750

Supply of Fluorouracil 25MG/ML Injections to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #12Fluorouracil 50MG/ML InjectionAwardedRenewalPublished value£236,261

Supply of Fluorouracil 50MG/ML Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #13Gemcitabine 38MG/ML Concentrate For Solution For Infusion VialsAwardedRenewalPublished value£108,791

Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #14Gemcitabine 100MG/ML Concentrate For Solution For Infusion VialsAwardedRenewalPublished value£18,031

Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #15Gemcitabine Powder For Solution For Infusion VialsRenewalPublished value£125,603

Supply of Gemcitabine Powder For Solution For Infusion Vials to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #16Idarubicin Hydrochlioride Injection Powder For ReconstitutionRenewalPublished value£28,000

Supply of Idarubicin Hydrochlioride Injection Powder For Reconstitution to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #17Ifosfamide Injection Powder For ReconstitutionAwardedRenewalPublished value£2,721,676

Supply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #18Irinotecan Hydrochloride InjectionAwardedRenewalPublished value£248,266

Supply of Irinotecan Hydrochloride Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #19Lanreotide Injection Prefilled SyringesAwardedRenewalPublished value£4,686,468

Supply of Lanreotide Injection Prefilled Syringes to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #20Methotrexate Without Preservatives InjectionAwardedRenewalPublished value£304,589

Supply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #21Methotrexate Oral SolutionAwardedRenewalPublished value£56,000

Supply of Methotrexate Oral Solution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #22Mitomycin Injection Powder For ReconstitutionRenewalPublished value£495,141

Supply of Mitomycin Injection Powder For Reconstitution to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #23Oxaliplatin Vial SolutionAwardedRenewalPublished value£209,041

Supply of Oxaliplatin Vial Solution to NHS Scotland. The Authority has awarded presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #24Paclitaxel Concentrate For Intravenous InfusionAwardedRenewalPublished value£406,689

Supply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products
Lot #25Temozolomide CapsulesAwardedRenewalPublished value£145,833

Supply of Temozolomide Capsules to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Delivery: Scotland · All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014
Extensions: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).Variant bids: not allowed
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored · same split on all 41 lots
Quality: 5%Price: 95%
Published sub-criteria (2)
  • Logistics: 5%
  • price: 95%
Published award criteria (2)
  • Logistics: 5
  • Price: 95
Conditions of participation1
  • Technical & professional ability

    (a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.

    (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.

    (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.

    (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.

    Minimum: a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Tec…
What this means for your bid
  • Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
  • “Generic and Biosimilar Cancer Medicines” is a framework: the contest is a place on its panel, not a single contract.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
16 Sept 2022, 08:41 BST
Last source update
21 Apr 2023, 08:53 BST
Award evaluation window
17 Oct 2022 – …
Authority reference
NP39722
FTS notice number
2023/S 000-011419
Classification (CPV)
Pharmaceutical products
Delivery area
Scotland (UKM)
Official registry OCID
ocds-h6vhtk-0368ee Find a Tender
Contract terms
Electronic trading
e-invoicing allowed · electronic ordering · electronic payment
Review and risk notes
Review procedure

Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:

An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.

The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.

Publisher note: The estimated value referred to in Section II.I.5 and within each Lot covers the twenty-four (24) months contract duration and the full twenty-four (24) months extension options. The Goods within this procurement were separated and advertised as forty-one (41) categories, each of which was identified as a “Lot” Out of the 41 lots, 33 Lots have been awarded. For details of lots not awarded, or details of individual lines awarded within a lot contact the named person at head of notice (SC Ref:723470)

How it was run

Official notice
Run through: Public Contracts Scotland · Who buys & how to bid on PCS
Supplier login requiredLanguage: EN
Access & registration note: Free single registration for Scotland; PCS-Tender (Jaggaer) for full bidding
Appointment period ends
17 Oct 2022, 12:00 BST
Submission channel
{"electronicSubmission"}
Accepted languages
en
Bid validity
90 days from the deadline
Bids opened
17 Oct 2022, 12:00 BST
Detailed submission instructions & authority contactsFrom official release

www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ↗

Timeline

17 Oct 2022 → 21 Apr 2023 · 3 dates
  1. Admission / appointment period endsperiod end, not a bid countdown
    17 Oct 2022, 12:00 BST
  2. Bids opened
    17 Oct 2022, 12:00 BST
  3. Notice published
    21 Apr 2023, 08:53 BST

Notice history

1 event · 2 releases on Find a Tender
  1. Status changed to complete
    21 Apr 2023, 08:53 BST

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 29admitted to the panel · see the list ↓
Bids received 5busiest of 25 lots
Contracts signed 20latest 23 Dec 2022

33 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

  • Lot 1 Bendamustine Powder For Solution For Infusion

    Signed
    23 Dec 2022
    Value
    £94,841
    Status
    active

  • Lot 10 Doxorubicin Hydrochloride Injections

    Signed
    23 Dec 2022
    Value
    £64,942
    Status
    active

  • Lot 12 Fluorouracil 50MG/ML Injection

    Signed
    23 Dec 2022
    Value
    £254,428
    Status
    active

  • Lot 13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials

    Signed
    23 Dec 2022
    Value
    £101,239
    Status
    active

  • Lot 14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials

    Signed
    23 Dec 2022
    Value
    £17,172
    Status
    active

  • Lot 18 Irinotecan Hydrochloride Injection

    Signed
    23 Dec 2022
    Value
    £226,125
    Status
    active

  • Lot 19 Lanreotide Injection Prefilled Syringes

    Signed
    23 Dec 2022
    Value
    £2,785,640
    Status
    active

  • Lot 20 Methotrexate Without Preservatives Injection

    Signed
    23 Dec 2022
    Value
    £360,972
    Status
    active

  • Lot 21 Methotrexate Oral Solution

    Signed
    23 Dec 2022
    Value
    £55,538
    Status
    active

  • Lot 23 Oxaliplatin Vial Solution

    Signed
    23 Dec 2022
    Value
    £193,024
    Status
    active

  • Lot 24 Paclitaxel Concentrate For Intravenous Infusion

    Signed
    23 Dec 2022
    Value
    £346,754
    Status
    active

  • Lot 2 Capecitabine Tablets

    Signed
    23 Dec 2022
    Value
    £748,926
    Status
    active

  • Lot 25 Temozolomide Capsules

    Signed
    23 Dec 2022
    Value
    £117,608
    Status
    active

  • Lot 26 Vincristine Without Preservatives Injection

    Signed
    23 Dec 2022
    Value
    £132,132
    Status
    active

  • Lot 27 Vinorelbine Injection

    Signed
    23 Dec 2022
    Value
    £54,400
    Status
    active

  • Lot 28 Aprepitant Capsules

    Signed
    23 Dec 2022
    Value
    £116,863
    Status
    active

  • Lot 31 Octreotide Injection

    Signed
    23 Dec 2022
    Value
    £135,446
    Status
    active

  • Lot 32 Filgrastim Pre-Filled Syringe

    Signed
    23 Dec 2022
    Value
    £1,670,068
    Status
    active

  • Lot 33 Pemetrexed Powder For Solution For Infusion Vials

    Signed
    23 Dec 2022
    Value
    £161,249
    Status
    active

  • Lot 34 Pemetrexed (25Mg/Ml) Solution For Infusion Vials

    Signed
    23 Dec 2022
    Value
    £232,447
    Status
    active

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · Bendamustine Powder For Solution For Infusion4bids · 4 electronic · 4 from abroad0——
2 · Capecitabine Tablets3bids · 3 electronic · 3 from abroad0——
3 · Carboplatin Injection4bids · 4 electronic · 4 from abroad0——
4 · Cisplatin Injection3bids · 3 electronic · 3 from abroad0——
5 · Cyclophosphamide Injection, Powder For Reconstitution2bids · 2 electronic · 2 from abroad0——
6 · Cytarabine Injections1bids · 1 electronic · 1 from abroad0——
7 · Dacarbazine Injections1bids · 1 electronic · 1 from abroad0——
8 · Disodium Folinate Injection1bids · 1 electronic · 1 from abroad0——
9 · Docetaxel Concentrate For Solution For Infusion3bids · 3 electronic · 3 from abroad0——
10 · Doxorubicin Hydrochloride Injections3bids · 3 electronic · 3 from abroad0——
12 · Fluorouracil 50MG/ML Injection2bids · 2 electronic · 2 from abroad0——
13 · Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials3bids · 3 electronic · 3 from abroad0——
14 · Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials1bids · 1 electronic · 1 from abroad0——
17 · Ifosfamide Injection Powder For Reconstitution4bids · 4 electronic · 4 from abroad0——
18 · Irinotecan Hydrochloride Injection5bids · 5 electronic · 5 from abroad0——
19 · Lanreotide Injection Prefilled Syringes1bids · 1 electronic · 1 from abroad0——
20 · Methotrexate Without Preservatives Injection2bids · 2 electronic · 2 from abroad0——
21 · Methotrexate Oral Solution1bids · 1 electronic · 1 from abroad0——
23 · Oxaliplatin Vial Solution5bids · 5 electronic · 5 from abroad0——
24 · Paclitaxel Concentrate For Intravenous Infusion2bids · 2 electronic · 2 from abroad0——
25 · Temozolomide Capsules2bids · 2 electronic · 2 from abroad0——
Lot 262bids · 2 electronic0——
Lot 271bids · 1 electronic · 1 from abroad0——
Lot 283bids · 3 electronic · 3 from abroad0——
Lot 312bids · 2 electronic · 2 from abroad0——

Contracting authority & participating public bodies

The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")

Contracting authorityNHS & healthcareBody governed by public lawHealth Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, Scotland, EH12 9EBContact name, email, phone Published organisation website ↗

Dispute resolution & review bodies

  • Edinburgh Sheriff CourtReview body EdinburghContact email, phone

Framework contractors & participating bidders

29 commercial parties on the notice
Show 19 more suppliers

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.